Aspirin chemoprevention of colorectal and oesophageal cancers. An overview of the literature and homeopathic explanation.
Recent reports in the medical literature indicate that the regular consumption of aspirin reduces the risk of both colorectal and oesophageal cancers. This paper reviews the scientific evidence for and against this suggestion. In extension of the science, a homeopathic basis for protection is proposed. The homeopathic mechanism relates to the ability of aspirin to induce the symptoms suggestive of cancer in these organs. Since homeopathy employs small doses of the mother compound, perhaps low doses of aspirin could be used to reduce the risk of cancer in the general population or in patients with precancerous colorectal and oesophageal lesions. This approach would also help to minimize the risk of adverse aspirin side-effects on the digestive system. Furthermore, in patients with colorectal and oesophageal cancers, high doses of aspirin could be given to concentrate the pharmacological/homeopathic effects.
Morgan
G
G
Public Health Department, Iechyd Morgannwg Health, Swansea, UK.
D001241:Aspirin / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D006705:Homeopathy; D006801:Humans; D012307:Risk Factors
D001241:Aspirin